Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan 26;49(3):601-10.
doi: 10.1021/bi901579y.

Efavirenz binding to HIV-1 reverse transcriptase monomers and dimers

Affiliations

Efavirenz binding to HIV-1 reverse transcriptase monomers and dimers

Valerie A Braz et al. Biochemistry. .

Abstract

Efavirenz (EFV) is a nonnucleoside reverse transcriptase inhibitor (NNRTI) of HIV-1 reverse transcriptase (RT) used for the treatment of AIDS. RT is a heterodimer composed of p66 and p51 subunits; p51 is produced from p66 by C-terminal truncation by HIV protease. The monomers can form p66/p66 and p51/p51 homodimers as well as the p66/p51 heterodimer. Dimerization and efavirenz binding are coupled processes. In the crystal structure of the p66/p51-EFV complex, the drug is bound to the p66 subunit. The binding of efavirenz to wild-type and dimerization-defective RT proteins was studied by equilibrium dialysis, tryptophan fluorescence, and native gel electrophoresis. A 1:1 binding stoichiometry was determined for both monomers and homodimers. Equilibrium dissociation constants are approximately 2.5 microM for both p66- and p51-EFV complexes, 250 nM for the p66/p66-EFV complex, and 7 nM for the p51/p51-EFV complex. An equilibrium dissociation constant of 92 nM for the p66/p51-EFV complex was calculated from the thermodynamic linkage between dimerization and inhibitor binding. Binding and unbinding kinetics monitored by fluorescence were slow. Progress curve analyses revealed a one-step, direct binding mechanism with association rate constants k(1) of approximately 13.5 M(-1) s(-1) for monomers and heterodimer and dissociation rate constants k(-1) of approximately 9 x 10(-5) s(-1) for monomers. A conformational selection mechanism is proposed to account for the slow association rate. These results show that efavirenz is a slow, tight-binding inhibitor capable of binding all forms of RT and suggest that the NNRTI binding site in monomers and dimers is similar.

PubMed Disclaimer

Figures

Scheme 1
Scheme 1
Thermodynamic Linkage of NNRTI Binding and Subunit Dimerization
Scheme 2
Scheme 2
Mechanisms of Slow Binding Inhibition
Figure 1
Figure 1
Equilibrium dialysis data for p51. (A) wild-type p51 equilibrated with efavirenz for 5 days: (○) experimental values [Ibound]exp, and (•) calculated values [Ibound]calc from Dialfit using eqs A1a–Alc. (B) p51W401A equilibrated with efavirenz for 30 h: (○) [Ibound]exp, and (•) [Ibound]calc from Dialfit using eq A1a. Insets show residuals ([Ibound]exp – [Ibound]calc) versus total protein concentration [Protein]Tot in each measurement.
Figure 2
Figure 2
Structure of HIV-1 RT complexed with efavirenz (1FK9): p66 (purple), p51 (green), efavirenz (cyan), and tryptophans (red).
Figure 3
Figure 3
Association of efavirenz to (—) p66/p51 and (formula image) p51 monitored by tryptophan fluorescence at 5 °C. λex = 295 nm, λem = 340 nm. 20 μM p66/p51 (83% heterodimer) diluted to 2 μM prior to adding efavirenz; 4.5 μM p51 (97% monomer). [EFV]:[protein] 2:1.
FIGURE 4
FIGURE 4
Progress curves for p51W401A binding to efavirenz monitored by tryptophan fluorescence at 5 °C. λex = 295 nm, λem = 340 nm. 2.5 μM p51W401A; (formula image) 5 μM, (formula image) 8 μM, (formula image) 11 μM, and (—) 14 μM efavirenz. Data acquired at 30 s intervals for first 4–5 h, then at 5 min intervals. Data were fit to eq 2a to obtain kobs.
FIGURE 5
FIGURE 5
Progress curve analysis of efavirenz binding to (▲) p66/p51, (formula image) p51W401A, (formula image) p66W401A. Lines are fits to eq 3. Error bars give the range of average values from 2 experiments.
FIGURE 6
FIGURE 6
Dissociation of (formula image) p51W401A—EFV and (formula image) p66W401A—EFV complexes monitored by tryptophan fluorescence at 5 °C. λex = 295 nm, λem = 340 nm. Black curves are fits to eq 2b. Data acquired at 30 s intervals for first 4–5 h, then at 5 min intervals.
FIGURE 7
FIGURE 7
Blue Native polyacrylamide gel electrophoresis of p66 in the absence and presence of NNRTIs. (A) Monomer and homodimer binding to [14C] EFV: (lane 1) 2 μM p66W401A incubated 2 h with [14C] EFV, (lane 2) 5 μM p66 incubated 2 h with [14C] EFV, and (lane 3) 5 μM p66 incubated 1 wk with [14C] EFV. (B) wild-type p66 incubated 1 wk in the absence and presence of NNRTI 1 wk: (lane 1) Native Markers; (lane 2) 0.8 μM p66; (lane 3) 3 μM p66, 25 μM EFV; and (lane 4) 3 μM p66, 25 μM NVP.
FIGURE 8
FIGURE 8
Structures of HIV-1 (upper) RT (1DLO) and (lower) RT—EFV complex (1FK9). Polymerase domains: fingers (blue), palm (red), thumb (green), and connection (orange) subdomains; RNase H domain (magenta). Efavirenz (yellow) and contact residues (grey) are shown using the van der Waals radii.

Similar articles

Cited by

References

    1. di Marzo Veronese F, Copeland TD, DeVico AL, Rahman R, Oroszlan S, Gallo RC, Sarngadharan MG. Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science. 1986;231:1289–1291. - PubMed
    1. Hizi A, McGill C, Hughes SH. Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants. Proc. Natl. Acad. Sci. U.S.A. 1988;85:1218–1222. - PMC - PubMed
    1. Restle T, Muller B, Goody RS. Dimerization of human immunodeficiency virus type 1 reverse transcriptase. J. Biol. Chem. 1990;265:8986–8988. - PubMed
    1. Restle T, Muller B, Goody RS. RNase H activity of HIV reverse transcriptase is confined exclusively to the dimeric forms. FEBS Lett. 1992;300:97–100. - PubMed
    1. Le Grice SFJ, Naas T, Wohlgensinger B, Schatz O. Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer-associated p51 HIV-1 reverse transcriptase. EMBO J. 1991;10:3905–3911. - PMC - PubMed

Publication types

MeSH terms